Strategic partnerships CU Anschutz School of Medicine is actively engaging in collaborations with industry and healthcare networks, including a Bayer clinical trials alliance and a multi-year Oxford Medical Simulation partnership, signaling opportunities for vendor services in research support, clinical trial infrastructure, and simulation-based training.

Education modernization The institution is launching a accelerated and innovative MD program and developing educational video series with major organizations, suggesting demand for e-learning platforms, curriculum tools, accessibility solutions, and content production services.

Health tech adoption Current tech stack includes OpenAI, Microsoft 365, analytics and security tools, indicating openness to AI-driven research support, cloud-based collaboration, data security, and scale-ready health IT solutions.

Research and therapeutics Recent advances include nonhormonal GSM therapy development and animal-model osteoarthritis drug work funded with ARPA-H, highlighting opportunities to engage in translational research support, grant-funded projects, and biotech collaboration services.

Disparities and equity A stated commitment to decreasing health disparities and increasing health equity suggests alignment with patient access initiatives, DEI-focused solutions, community outreach platforms, and inclusive care training programs.